Xintela AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.xintela.se
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)phase_1_2
1 (50.0%)A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Xintela AB
- Target Recruit Count
- 6
- Registration Number
- NCT05549609
- Locations
- 🇸🇪
Clinical Trial Center (CTC), Gothenburg, Sweden
🇸🇪Burn Centre, Linköping University Hospital, Linköping, Sweden
🇸🇪Clinical Research Unit, Lund, Sweden
News
No news found